AdenoPaint
Manufacturing · Georgia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
960 Johnson Ferry Rd Ste 530, Sandy Spri...Website
www.adenopaint.comRevenue
<$5 MillionIndustry
About AdenoPaint
AdenoPaint, LLC is a seed stage medical device company focused on developing a novel adenosine-releasing cardiac guidewire, known as Adenowire, aimed at improving outcomes for patients undergoing percutaneous coronary intervention (PCI). The guidewire is designed to prevent and treat microvascular obstruction (MVO), shorten PCI procedure times, and reduce the need for additional drugs and devices. Their innovative technology leverages various advancements to enhance patient care in the context of coronary artery disease. AdenoPaint targets healthcare providers and institutions involved in interventional cardiology.Explore more
SIC Code 38,382NAICS Code 33,339Show more
AdenoPaint Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
AdenoPaint Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AdenoPaint
Sign Up For FreeTo access detailed company insights
AdenoPaint, LLC is a seed stage medical device company focused on developing a novel adenosine-releasing cardiac guidewire, known as Adenowire, aimed at improving outcomes for patients undergoing percutaneous coronary intervention (PCI). The guidewire is designed to prevent and treat microvascular obstruction (MVO), shorten PCI procedure times, and... Read More
